Literature DB >> 10672229

Oxidative phosphorylation disease diagnosis.

J M Shoffner1.   

Abstract

Although the mtDNA encodes only 13 polypeptide subunits of the OXPHOS enzymes, approximately 1,000 proteins are estimated to be necessary for proper OXPHOS function. Over the past 10 years a wide variety of adult and pediatric OXPHOS diseases were found to be caused by or associated with mitochondrial DNA (mtDNA) mutations and nuclear DNA mutations. These advances enhanced the ability to definitively diagnose patients, develop management plans, and provide genetic counseling. Recently described nuclear DNA and mtDNA mutations are enhancing our understanding of this complex group of diseases. The impact of these advances on our understanding of OXPHOS disease pathogenesis will be reviewed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10672229     DOI: 10.1111/j.1749-6632.1999.tb07817.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

1.  Frequency of dystrophic muscle abnormalities in chronic progressive external ophthalmoplegia: analysis of 86 patients.

Authors:  B H Kiyomoto; C H Tengan; C K Costa; A S Oliveira; B Schmidt; A A Gabbai
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

2.  New MT-ND6 and NDUFA1 mutations in mitochondrial respiratory chain disorders.

Authors:  Natsumi Uehara; Masato Mori; Yoshimi Tokuzawa; Yosuke Mizuno; Shunsuke Tamaru; Masakazu Kohda; Yohsuke Moriyama; Yutaka Nakachi; Nana Matoba; Tetsuro Sakai; Taro Yamazaki; Hiroko Harashima; Kei Murayama; Keisuke Hattori; Jun-Ichi Hayashi; Takanori Yamagata; Yasunori Fujita; Masafumi Ito; Masashi Tanaka; Ken-Ichi Nibu; Akira Ohtake; Yasushi Okazaki
Journal:  Ann Clin Transl Neurol       Date:  2014-04-28       Impact factor: 4.511

3.  Convergence and divergence in gene expression among natural populations exposed to pollution.

Authors:  Marla A Fisher; Marjorie F Oleksiak
Journal:  BMC Genomics       Date:  2007-04-25       Impact factor: 3.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.